This text is a result of machine translation.
Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying
The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?
Feb 21, 2022 02:30 PM
Fabless Semiconductor Startup Senscomm Raises over CNY 300 Million from Series A2 Round
Senscomm upholds the mission of reforming the wireless network and human-computer interaction pattern to promote the development of communication technology and make life more intelligent and convenient
Updated 58 mins ago
Cell Therapy Developer Senlang Bio Raises CNY 200 Million in New Funding Round
Founded in 2016, Hebei Senlang Bio is a clinical-stage biotechnology company dedicated to utilizing cell and gene engineering technologies to generate innovative and transformative cellular immunotherapies for solid and hematologic cancers.
Updated 5 hours ago
Changchun hi tech: nine directors, supervisors and senior management personnel increased their holdings of 84700 shares in the company
Consumer electronics stocks continued to decline
Exclusive Interview with Zhou Mi, Managing Partner of Puhua Capital
May 12, 2022 05:41 PM